Targeted Methylation of Two Tumor Suppressor Genes Is Sufficient to Transform Mesenchymal Stem Cells into Cancer Stem/Initiating Cells
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Although DNA hypermethylation within promoter CpG islands is highly correlated with tumorigenesis, it has not been established whether DNA hypermethylation within a specific tumor suppressor gene (TSG) is sufficient to fully transform a somatic stem cell. In this study, we addressed this question using a novel targeted DNA methylation technique to methylate the promoters of HIC1 and RassF1A, two well-established TSGs, along with a two-component reporter system to visualize successful targeting of human bone marrow–derived mesenchymal stem cells (MSC) as a model cell system. MSCs harboring targeted promoter methylations of HIC1/RassF1A displayed several features of cancer stem/initiating cells including loss of anchorage dependence, increased colony formation capability, drug resistance, and pluripotency. Notably, inoculation of immunodeficient mice with low numbers of targeted MSC resulted in tumor formation, and subsequent serial xenotransplantation and immunohistochemistry confirmed the presence of stem cell markers and MSC lineage in tumor xenografts. Consistent with the expected mechanism of TSG hypermethylation, treatment of the targeted MSC with a DNA methyltransferase inhibitor reversed their tumorigenic phenotype. To our knowledge, this is the first direct demonstration that aberrant TSG hypermethylation is sufficient to transform a somatic stem cell into a fully malignant cell with cancer stem/initiating properties. Cancer Res; 71(13); 4653–63. ©2011 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206 · cited 1×
“Bone marrow-derived MSCs are known to play important roles in cancer progression and metastasis (33-35).”
BackgroundPhenotypic plasticity and the epigenetics of human disease
Feinberg, A. P. (2007) · Nature · doi:10.1038/nature05919 · Cited by 1,613 · cited 2×
“Hypomethylation and/or hypermethylation of specific loci, including tumor suppressor loci, were strongly associated with transformation and carcinogenesis (7, 8), and genetic knockout of the DNA methyltransferases (DNMTs), resulted in global hypomethylation and tumorigenesis (9, 10).”
BackgroundInduction of tumors in mice by genomic hypomethylation
Gaudet, F., Hodgson, J. G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J. W., Leonhardt, H., & Jaenisch, R. (2003) · Science · doi:10.1126/science.1083558 · Cited by 1,499 · cited 1×
“Hypomethylation and/or hypermethylation of specific loci, including tumor suppressor loci, were strongly associated with transformation and carcinogenesis (7, 8), and genetic knockout of the DNA methyltransferases (DNMTs), resulted in global hypomethylation and tumorigenesis (9, 10).”
BackgroundCancer stem cells: an old idea–a paradigm shift
Wicha, M. S., Liu, S., & Dontu, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3153 · Cited by 1,378 · cited 1×
“These cells may arise either from de-regulated somatic stem cells or from de-differentiated mature cells (4, 7, 8, 39-42).”
BackgroundOhm, J. E., McGarvey, K. M., Yu, X., Cheng, L., Schuebel, K. E., Cope, L., Mohammad, H. P., Chen, W., Daniel, V. C., Yu, W., et al. (2007) · Nature Genetics · doi:10.1038/ng1972 · Cited by 1,130 · cited 1×
“It has been reported that several hypermethylated genes, including HIC1 and RassF1A, in adult cancer are unmethylated in embryonic stem cells and only partially methylated in embryonic carcinomas (43).”
BackgroundIn vitro Hepatic Differentiation of Human Mesenchymal Stem Cells
Lee, K., Kuo, T. K., Whang–Peng, J., Chung, Y., Lin, C., Chou, S., Chen, J., Chen, Y., & Lee, O. K. (2004) · Hepatology · doi:10.1002/hep.20469 · Cited by 865
Self-citationThe Salvador–Warts–Hippo pathway — an emerging tumour-suppressor network
Harvey, K., & Tapon, N. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2070 · Cited by 628 · cited 4×
“Abnormal SWH signaling pathway has been associated with tumorigenesis in both mammalian cells and Drosophila (26, 27), and RassF1A is a SWH pathway component controlling cellular proliferation, survival, anti-apoptosis, organ size and cell contact inhibition (20, 28).”
BackgroundInfluentialAdult human mesenchymal stem cell as a target for neoplastic transformation
Serakinci, N., Guldberg, P., Burns, J. S., Abdallah, B., Schrødder, H., Jensen, T., & Kassem, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207651 · Cited by 350 · cited 1×
“Bone marrow-derived MSCs are known to play important roles in cancer progression and metastasis (33-35).”
BackgroundMicroenvironmental regulation of cancer development
Hu, M., & Polyak, K. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2007.12.006 · Cited by 330 · cited 2×
“By providing a microenvironment that enhances primary tumor growth, invasiveness, and metastasis, MSCs have the capacity to mobilize to other organs, providing a niche suitable for the disseminated cancer cells to metastasize to distant tissues (33).”
Background
Cited by
A decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871
Papaccio, F., Paino, F., Regad, T., Papaccio, G., Desiderio, V., & Tirino, V. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0138 · Cited by 292
Castells, M., Thibault, B., Delord, J.-P., & Couderc, B. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13089545 · Cited by 285
de Groote, M. L., Verschure, P. J., & Rots, M. G. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks863 · Cited by 180
“Some alternative gene-specific technologies to induce DNA methylation have been described, including RNA-directed (46) and methylated oligo-induced (47) methylation, but the general applicability of such approaches to silence any gene of interest is unclear.”
BackgroundRecent discoveries concerning the tumor - mesenchymal stem cell interactions
Lazennec, G., & Lam, P. Y. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.10.004 · Cited by 117
Metadata
- Authors
- Teng, I.-W., Hou, P.-C., Lee, K.-D., Chu, P.-Y., Yeh, K.-T., Jin, V. X., Tseng, M.-J., Tsai, S.-J., Chang, Y.-S., Wu, C.-S., Sun, H. S., Tsai, K.-D., Jeng, L.-B., Nephew, K. P., Huang, T. H.-M., Hsiao, S.-H., & Leu, Y.-W.
- Venue
- Cancer Research
- Published
- 2011-06-30
- Volume
- 71
- Issue
- 13
- Pages
- 4653-4663
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2113633164
- Cited by
- 98
- References
- 11
- FWCI
- 4.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Targeted Methylation of Two Tumor Suppressor Genes Is Sufficient to Transform Mesenchymal Stem Cells into Cancer Stem/Initiating Cells. https://app.cochat.ai/papers/10.1158/0008-5472.can-10-3418
- The paper
- Teng, I.-W., Hou, P.-C., Lee, K.-D., Chu, P.-Y., Yeh, K.-T., Jin, V. X., Tseng, M.-J., Tsai, S.-J., Chang, Y.-S., Wu, C.-S., Sun, H. S., Tsai, K.-D., Jeng, L.-B., Nephew, K. P., Huang, T. H.-M., Hsiao, S.-H., & Leu, Y.-W. (2011). Targeted Methylation of Two Tumor Suppressor Genes Is Sufficient to Transform Mesenchymal Stem Cells into Cancer Stem/Initiating Cells. Cancer Research. https://doi.org/10.1158/0008-5472.can-10-3418
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.